Global Market For Drug Device Combination Products To Reach $30.5 Billion In 2017
BCC Research is a leading information resource producing high-quality market research reports, newsletters, and conferences.BCC Research is a leading market research company providing industry reports for categories such as biotech, chemicals, energy, healthcare, information technology, nanotech, pharma and plastics.
- (1888PressRelease) November 29, 2012 - Wellesley, Mass. - According to a new technical market research report, GLOBAL MARKETS FOR DRUG DEVICE COMBINATIONS (PHM045C) from BCC Research (www.bccresearch.com), the market for global drug device combination products was valued at $18.5 billion in 2011 and should reach $19 billion in 2012. Total market value is expected to reach $30.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 9.9%.
The market for drug device combination products can be broken down into five major segments: coronary stents, photodynamic therapies, antimicrobial catheters, orthopedic applications, and all other segments.
Coronary stents are expected to have a value of $5.8 billion in 2012 and $8.2 billion in 2017, a CAGR of 7.2%.
Photodynamic therapies as a segment should total $1.7 billion in 2012 and $2.6 billion in 2017, a CAGR of 8.9%.
Antimicrobial catheters are expected to total $6.6 billion in 2012 and $11.7 billion in 2017, a CAGR of 12.1%.
The segment made up of orthopedic applications (cements and bone substitutes) should be valued at $2.8 billion in 2012 and $4.1 billion in 2017, a CAGR of 7.9%.
The combination products industry includes makers of drug-delivery systems, gene therapy systems, personalized medicine drug device combinations, biological-device combinations, nanotechnology, and certain other products for diagnostic and therapeutic treatments of cardiovascular, metabolic, oncologic, and other disorders.
Combination products are therapeutic and/or diagnostic products that combine elements of drugs, devices, and/or biological products. An estimated 30% of all new healthcare products under development are "combination products" involving medical devices embedded with pharmaceutical or biologics components. The classic example of a combination product that revolutionized patient care is the drug-eluting coronary stent.
This report will help its readers:
• Forecast the market size for drug device combination products in terms of dollar and unit sales
• Classify the market size for drug device combination products by geographical region in terms of dollar and unit sales
• Highlight the roles played by major stakeholders and players
• Provide an overview of the activities of influential companies
• Examine crucial, innovative breakthroughs by means of a detailed patent analysis.
This report will be valuable to many industry participants, including the following:
• Drug delivery system makers
• Drug device manufacturers
• End users and distributors
• Academic and research institutions
• Financial institutions.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam